June 25, 2025 a 01:00 pm
SOLV: Fundamental Ratio Analysis - Solventum Corporation
Solventum Corporation, a healthcare company, exhibits strong growth potential in its diversified segments. With a balanced approach towards Medsurg, Dental Solutions, Health Information Systems, and Purification & Filtration, the company is poised to capitalize on industry needs. However, investors should be mindful of sector-specific risks and market volatility.
Fundamental Rating
The current fundamental rating reflects a stable outlook with certain areas performing better than others.
| Category | Score | Visualization |
|---|---|---|
| Overall | 3 | |
| Discounted Cash Flow | 5 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 2 |
Historical Rating
Historic ratings provide context to the current scores, showcasing trends over time.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-06-24 | 3 | 5 | 4 | 4 | 1 | 1 | 2 |
| Previous | 0 | 5 | 4 | 4 | 1 | 1 | 2 |
Analyst Price Targets
Analyst targets suggest a range with potential growth, although consensus is steady.
| High | Low | Median | Consensus |
|---|---|---|---|
| $82 | $75 | $78.5 | Hold |
Analyst Sentiment
Analyst sentiment reflects a mixed outlook with the majority holding.
| Recommendation | Frequency | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 1 | |
| Hold | 4 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Solventum Corporation presents a balanced investment opportunity given its healthcare-centered portfolio. The current ratings highlight a stable outlook, though profitability ratios present room for improvement. The stock’s performance might be influenced by broader healthcare industry trends and regulatory environments. While analyst consensus suggests holding, potential investors should weigh growth prospects against current market conditions. Cautious optimism is advised as the company navigates its strategic path.